FluMist approved for self-administration in the US - astrazeneca.com
WEB1 day ago · FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from …
FDA approves first flu vaccine that can be self-administered at …
WEB21 hours ago · FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003. ... “Today’s approval of the first influenza vaccine for ...
Nasal Flu Vaccine Is Approved for At-Home Use - The New York …
WEB22 hours ago · Sept. 20, 2024, 2:46 p.m. ET. The Food and Drug Administration on Friday authorized at-home use of FluMist, opening the door for needle-shy people to have easy access to a nasal spray vaccine that ...
FLUMIST approved for self-administration in the US
WEB20 hours ago · Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said: “The approval of FLUMIST for self-administration is an important step forward in making vaccines more ...
FDA approves ‘FluMist,' says no healthcare provider needed
WEB1 day ago · The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind. FluMist is the first vaccine to ...
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
WEB1 day ago · Today, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes ...
FDA approves first self-administered flu vaccine spray - CBS News
WEB21 hours ago · The FDA says patients will still need to get a prescription for the vaccine from a health care provider. AstraZeneca says it plans to sell FluMist directly to patients through an online pharmacy ...
FDA approves first at-home flu vaccine in U.S., a nasal spray
WEB22 hours ago · Sept. 20, 2024. Senior Writer, Infectious Diseases. The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home ...
US Food and Drug Administration accepts for review AstraZeneca…
WEBOct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA). If approved, FluMist will be the first flu vaccine available to be self-administered by eligible patients or administered by caregivers ...
US FDA approves AstraZeneca's flu vaccine for self-administration
WEB1 day ago · Sept 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's (AZN.L), opens new tab nasal spray flu vaccine for self-administration, making it the first ...